Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
6.29Enterprise Value over EBIT
VS
Market
Sector
Industry
History
$ 3.74Close
$ 0.43 - $ 3.74 52-Week Range
Ticker Information
Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYTOMX THERAPEUTICS INC - Enterprise Value over EBIT Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTMX - EV/EBIT Historical data
| Date | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
|---|---|---|---|
| 6/30/2025 | $ 48.23M | $ 303.13M | 6.29 |
| 3/31/2025 | $ 41.84M | $ 131.24M | 3.14 |
| 12/31/2024 | $ 32.09M | $ 19.73M | 0.61 |
| 9/30/2024 | $ 15.06M | $ 47.25M | 3.14 |
| 6/30/2024 | $ 15.08M | $ 59.76M | 3.96 |
| 3/31/2024 | $ 20.47M | $ 302.25M | 14.76 |
| 12/31/2023 | $ 3.32M | $ 165.87M | 49.91 |
| 9/30/2023 | $ -26.54M | $ 69.4M | 0 |
| 6/30/2023 | $ -55.65M | $ 66.13M | 0 |
| 3/31/2023 | $ -78.74M | $ 69.7M | 0 |
Key Performance Insights, Last 5 Years
- CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
- Over the past 5 years, CYTOMX THERAPEUTICS INC's average EV/EBIT has been 11.69.
- The median EV/EBIT for CYTOMX THERAPEUTICS INC during this period was 3.96
- CYTOMX THERAPEUTICS INC reached its highest EV/EBIT over the past 5 years at 49.91.
- The lowest EV/EBIT recorded by CYTOMX THERAPEUTICS INC in the same timeframe 0.61
CYTOMX THERAPEUTICS INC's EV/EBIT vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBIT Benchmarks
Similar metrics to EV/EBIT:
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Enterprise Value over EBIT
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].EV / EBIT
(=) EV/EBIT EV/EBIT for CYTOMX THERAPEUTICS INC is calculated as follows: EV [ $ 171.6M ] / EBIT [ $ -67.97M ]
(=) EV/EBIT [ 0 ] CTMX - Enterprise Value over EBIT, Last 5 years
0.61
Minimum
Dec 31, 2024
49.91
Maximum
Dec 31, 2023
11.69
Average
3.96
Median
EV/EBIT Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
| filtered constituents | 2.25K |
|---|---|
| min | 0.05 |
| max | 62.03 |
| average | 19.91 |
| median | 16.78 |
| std | 12.32 |